Details

Autor(en) / Beteiligte

• Liu, Xin-guang
• Bai, Xiao-chuan
• Chen, Fang-ping
• Cheng, Yun-feng
• Dai, Ke-sheng
• Fang, Mei-yun
• Feng, Jian-Ming
• Gong, Yu-ping
• Guo, Tao
• Guo, Xin-hong
• Han, Yue
• Hong, Luo-jia
• Hu, Yu
• Hua, Bao-lai
• Huang, Rui-bing
• Li, Yan
• Peng, Jun
• Shu, Mi-mi
• Sun, Jing
• Sun, Pei-yan
• Sun, Yu-qian
• Wang, Chun-sen
• Wang, Shu-jie
• Wang, Xiao-min
• Wu, Cong-ming
• Wu, Wen-man
• Yan, Zhen-yu
• Yang, Feng-e
• Yang, Lin-hua
• Yang, Ren-Chi
• Yang, Tong-hua
• Ye, Xu
• Zhang, Guang-sen
• Zhang, Lei
• Zheng, Chang-cheng
• Zhou, Hu
• Zhou, Min
• Zhou, Rong-fu
• Zhou, Ze-ping
• Zhu, Hong-li
• Zhu, Tie-nan
• Hou, Ming

Titel

Chinese guidelines for treatment of adult primary immune thrombocytopenia

Ist Teil von

• International journal of hematology, 2018-06, Vol.107 (6), p.615-623

Ort / Verlag

Tokyo: Springer Japan

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• Primary immune thrombocytopenia (ITP) is a bleeding disorder commonly encountered in clinical practice. The International Working Group (IWG) on ITP has published several landmark papers on terminology, definitions, outcome criteria, bleeding assessment, diagnosis, and management of ITP. The Chinese consensus reports for diagnosis and management of adult ITP have been updated to the 4th edition. Based on current consensus positions and new emerging clinical evidence, the thrombosis and hemostasis group of the Chinese Society of Hematology issued Chinese guidelines for management of adult ITP, which aim to provide evidence-based recommendations for clinical decision making.